Pharmacoeconomics and formulary decision making.

Area of Science:

• Health Economics
• Pharmaceutical Policy
• Clinical Pharmacy

Background:

• Formulary management and drug policies are key tactics for controlling medication use.
• Pharmacoeconomic data increasingly supports formulary decision-making at various levels.

Purpose of the Study:

• To explore the role of pharmacoeconomics in formulary decision-making.
• To discuss strategies for incorporating economic evaluations into formulary actions.

Main Methods:

• Review of pharmacoeconomic assessment strategies.
• Discussion of economic modeling techniques and local research.
• Evaluation of criteria for pharmacoeconomic literature.

Main Results:

• Pharmacoeconomics supports drug inclusion/exclusion and cost-effective utilization guidelines.
• Formularies should optimize therapeutic outcomes while managing costs, not just select cheapest options.
• Economic assessments ensure maximum health outcome per dollar spent.

Conclusions:

• Pharmacoeconomic assessments are crucial for evidence-based formulary management.
• Integrating economic evaluations enhances formulary value and patient care.
• Strategies exist to effectively incorporate pharmacoeconomics into US hospital formulary processes.